You are currently in the confidential and secure reporting structure of EthicsPoint. Below are the choices available to you. Please click on the arrow (Arrow Example) to select the type of report you would like to make.

Insys Therapeutics, Inc.
Accounting and Financial
  • Accounting and Auditing Matters
  • Securities Violations
  • Disclosure of Confidential Information
  • Health Insurance Portability and Accountability Act
Fraud and Theft
  • Conflict of Interest
  • Embezzlement
  • Falsification of Contracts, Reports or Records
  • Theft
Gifts and Donations
  • Gifts and Entertainment - Refers to the inappropriate offering, solicitation or accepting of items of more than nominal value from vendors, customers or other third parties in a capacity as an employee of the Company.
Harassment and Inappropriate Behavior
  • Discrimination or Harassment
  • Misconduct or Inappropriate Behavior
  • Substance Abuse
  • Violence or Threat
  • Clinical Trials - Misconduct in connection with any clinical trial, for instance, falsifying any study results or reports; failure to maintain adequate documentation as required by the IRB-approved study protocol; failure to follow the IRB study protocol; making a false or misleading statement in any material submitted to an IRB; making a false or misleading statement in any study report or other documentation, including the failure to report negative results; violation of adverse event reporting requirements; violation of FDA or ICH standards for the conduct of human clinical trials (e.g., ICH E6 Good Clinical Practices Consolidated Guidance or 21 C.F.R. parts 50, 54, 56).
Sales, Marketing, and Advertising Practices
  • Best Price and Other Price Reporting
  • PhRMA Code on Interactions with Healthcare Professionals
Standards and Practices
  • Failure to comply with Quality, Regulatory, or Manufacturing Standards - Any violation of the pharmaceutical or biological products cGMPs or company standards regarding Manufacturing, Laboratory Practices, Clinical Practices and other applicable government regulations and guidelines. Any violation of applicable cGMPs (21 C.F.R. parts 210, 211, 600, 610)
Workplace Safety
  • Safety, Health and the Environment - Failure to provide a safe working environment or training required by company policies; failure to report accidents, etc. concealing of actual or potential environmental damage; failure to comply with environmental laws.